# Aligos Therapeutics, Inc.: Form SC 13D, filed Oct 30, 2020

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: SC 13D
- Filed: 2020-10-30
- Accepted by EDGAR: Oct 30, 2020, 16:25 ET
- Period: not reported
- Accession: 0001193125-20-282616
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000119312520282616/d98591dsc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000119312520282616/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000119312520282616/d98591dsc13d.htm

Filed Oct 30, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-282616. Last ingested by Listed: Nov 14, 2026, 12:59 ET. No prices; not investment advice.
